A 89Zr-labeled lipoplex nanosystem for image-guided gene delivery: design, evaluation of stability and in vivo behavior

Istvan Hajdu,1 Amal Makhlouf,1,2 Viswas Raja Solomon,3 Deborah Michel,1 Mays Al-Dulaymi,1 Kishor M Wasan,1 Humphrey Fonge,3,4 Ildiko Badea1 1Drug Discovery and Development Research Group, College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada; 2Department of Ph...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hajdu I, Makhlouf A, Solomon VR, Michel D, Al-Dulaymi M, Wasan KM, Fonge H, Badea I
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/bc08072580f6473bb919b86b7689ab28
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bc08072580f6473bb919b86b7689ab28
record_format dspace
spelling oai:doaj.org-article:bc08072580f6473bb919b86b7689ab282021-12-02T05:39:32ZA 89Zr-labeled lipoplex nanosystem for image-guided gene delivery: design, evaluation of stability and in vivo behavior1178-2013https://doaj.org/article/bc08072580f6473bb919b86b7689ab282018-11-01T00:00:00Zhttps://www.dovepress.com/a-89zr-labeled-lipoplex-nanosystem-for-image-guided-gene-delivery-desi-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Istvan Hajdu,1 Amal Makhlouf,1,2 Viswas Raja Solomon,3 Deborah Michel,1 Mays Al-Dulaymi,1 Kishor M Wasan,1 Humphrey Fonge,3,4 Ildiko Badea1 1Drug Discovery and Development Research Group, College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada; 2Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, 12411 Cairo, Egypt; 3Department of Medical Imaging, College of Medicine, University of Saskatchewan, Saskatoon, SK S7N 0W8, Canada; 4Department of Medical Imaging, Royal University Hospital Saskatoon, SK S7N 0W8, Canada Background: With the advances in radiopharmaceutical research, the development of image-guided therapy has become a major interest. While the development of theranostic nanotherapeutics is frequently associated with cancer chemotherapy, phototherapy and radiotherapy, there is little information available on the in vivo monitoring of gene delivery systems and the application of image-guided approach in gene therapy. The goal of this work was to determine the in vivo behavior of DNA delivery nanosystems - based on cationic gemini surfactants – designed for image-guided gene therapy. We tested the feasibility of monitoring tumor accumulation of gene delivery nanoparticles by positron emission tomography.Methods: To be able to conjugate radiotracers to the nanoparticles, a deferoxamine-modified gemini surfactant was synthesized, DNA-containing lipoplex nanoparticles were formulated, and radiolabeled with Zirconium-89 (89Zr). The pharmacokinetics and biodistribution of 89Zr labeled surfactant and 89Zr labeled nanoparticles were monitored in mice by microPET/CT imaging and ex vivo gamma counting. Results: Modification of the nanoparticles with deferoxamine did not alter their physicochemical properties. The radiolabeled nanoparticles (labeling efficiency of 95±3%) were stable in PBS and serum. The biological half-life of the 89Zr labeled nanoparticles was significantly higher compared to 89Zr labeled surfactant. As expected, the nanoparticles had significantly higher liver accumulation than the radiolabeled surfactant alone and lower kidney accumulation. Tumor uptake was detected at 2 hours post injection and decreased throughout the 3-day monitoring. Conclusion: We propose that radiolabeling DNA delivery lipoplex nanosystems is a promising approach for the design and optimization of image-guided nanomedicines, especially in the context of cancer gene therapy.Keywords: gemini surfactant, pharmacokinetic, biodistribution, melanoma, microPET imaging Hajdu IMakhlouf ASolomon VRMichel DAl-Dulaymi MWasan KMFonge HBadea IDove Medical Pressarticlegemini surfactantpharmacokineticbiodistributionmelanomamicroPET imagingMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 13, Pp 7801-7818 (2018)
institution DOAJ
collection DOAJ
language EN
topic gemini surfactant
pharmacokinetic
biodistribution
melanoma
microPET imaging
Medicine (General)
R5-920
spellingShingle gemini surfactant
pharmacokinetic
biodistribution
melanoma
microPET imaging
Medicine (General)
R5-920
Hajdu I
Makhlouf A
Solomon VR
Michel D
Al-Dulaymi M
Wasan KM
Fonge H
Badea I
A 89Zr-labeled lipoplex nanosystem for image-guided gene delivery: design, evaluation of stability and in vivo behavior
description Istvan Hajdu,1 Amal Makhlouf,1,2 Viswas Raja Solomon,3 Deborah Michel,1 Mays Al-Dulaymi,1 Kishor M Wasan,1 Humphrey Fonge,3,4 Ildiko Badea1 1Drug Discovery and Development Research Group, College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada; 2Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, 12411 Cairo, Egypt; 3Department of Medical Imaging, College of Medicine, University of Saskatchewan, Saskatoon, SK S7N 0W8, Canada; 4Department of Medical Imaging, Royal University Hospital Saskatoon, SK S7N 0W8, Canada Background: With the advances in radiopharmaceutical research, the development of image-guided therapy has become a major interest. While the development of theranostic nanotherapeutics is frequently associated with cancer chemotherapy, phototherapy and radiotherapy, there is little information available on the in vivo monitoring of gene delivery systems and the application of image-guided approach in gene therapy. The goal of this work was to determine the in vivo behavior of DNA delivery nanosystems - based on cationic gemini surfactants – designed for image-guided gene therapy. We tested the feasibility of monitoring tumor accumulation of gene delivery nanoparticles by positron emission tomography.Methods: To be able to conjugate radiotracers to the nanoparticles, a deferoxamine-modified gemini surfactant was synthesized, DNA-containing lipoplex nanoparticles were formulated, and radiolabeled with Zirconium-89 (89Zr). The pharmacokinetics and biodistribution of 89Zr labeled surfactant and 89Zr labeled nanoparticles were monitored in mice by microPET/CT imaging and ex vivo gamma counting. Results: Modification of the nanoparticles with deferoxamine did not alter their physicochemical properties. The radiolabeled nanoparticles (labeling efficiency of 95±3%) were stable in PBS and serum. The biological half-life of the 89Zr labeled nanoparticles was significantly higher compared to 89Zr labeled surfactant. As expected, the nanoparticles had significantly higher liver accumulation than the radiolabeled surfactant alone and lower kidney accumulation. Tumor uptake was detected at 2 hours post injection and decreased throughout the 3-day monitoring. Conclusion: We propose that radiolabeling DNA delivery lipoplex nanosystems is a promising approach for the design and optimization of image-guided nanomedicines, especially in the context of cancer gene therapy.Keywords: gemini surfactant, pharmacokinetic, biodistribution, melanoma, microPET imaging 
format article
author Hajdu I
Makhlouf A
Solomon VR
Michel D
Al-Dulaymi M
Wasan KM
Fonge H
Badea I
author_facet Hajdu I
Makhlouf A
Solomon VR
Michel D
Al-Dulaymi M
Wasan KM
Fonge H
Badea I
author_sort Hajdu I
title A 89Zr-labeled lipoplex nanosystem for image-guided gene delivery: design, evaluation of stability and in vivo behavior
title_short A 89Zr-labeled lipoplex nanosystem for image-guided gene delivery: design, evaluation of stability and in vivo behavior
title_full A 89Zr-labeled lipoplex nanosystem for image-guided gene delivery: design, evaluation of stability and in vivo behavior
title_fullStr A 89Zr-labeled lipoplex nanosystem for image-guided gene delivery: design, evaluation of stability and in vivo behavior
title_full_unstemmed A 89Zr-labeled lipoplex nanosystem for image-guided gene delivery: design, evaluation of stability and in vivo behavior
title_sort a 89zr-labeled lipoplex nanosystem for image-guided gene delivery: design, evaluation of stability and in vivo behavior
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/bc08072580f6473bb919b86b7689ab28
work_keys_str_mv AT hajdui anbsp89zrlabelednbsplipoplexnanosystemforimageguidedgenedeliverydesignevaluationofstabilityandinvivobehavior
AT makhloufa anbsp89zrlabelednbsplipoplexnanosystemforimageguidedgenedeliverydesignevaluationofstabilityandinvivobehavior
AT solomonvr anbsp89zrlabelednbsplipoplexnanosystemforimageguidedgenedeliverydesignevaluationofstabilityandinvivobehavior
AT micheld anbsp89zrlabelednbsplipoplexnanosystemforimageguidedgenedeliverydesignevaluationofstabilityandinvivobehavior
AT aldulaymim anbsp89zrlabelednbsplipoplexnanosystemforimageguidedgenedeliverydesignevaluationofstabilityandinvivobehavior
AT wasankm anbsp89zrlabelednbsplipoplexnanosystemforimageguidedgenedeliverydesignevaluationofstabilityandinvivobehavior
AT fongeh anbsp89zrlabelednbsplipoplexnanosystemforimageguidedgenedeliverydesignevaluationofstabilityandinvivobehavior
AT badeai anbsp89zrlabelednbsplipoplexnanosystemforimageguidedgenedeliverydesignevaluationofstabilityandinvivobehavior
_version_ 1718400319179718656